The Wall Street Journal recently reported on current research involving dental pulp stem cells [DPSC]. Researchers worldwide, including StemSave’s Chief Scientific Adviser, Dr. Jeremy Mao of Columbia University, are making advances in restoring tooth tissue and regenerating entire teeth using dental pulp stem cells. Current studies are in the animal model stage but researchers anticipate entering human clinical trials in the near future.
Dr. D’Souza, a professor at the Baylor College of Dentistry explains that “You can tailor [dental pulp stem cells] for the needs at hand, and that makes it a very exciting technology for the treatment of pulp disease and of course applications to other systems in the body.” In addition to regenerating teeth and tooth related tissue, dental stem cells possess a characteristic scientists refer to as ‘plasticity.’ Dental pulp stem cells can be differentiated into a broad range of tissue types, such as bone, cardiomyocites, insulin-producing pancreatic beta cells, muscle, and neurons. Researchers around the world are developing treatments utilizing DPSC to treat a wide array of disease, trauma and injury.
The WSJ report is yet another example of advancements taking place in regenerative medicine and, more specifically, the potential for dental pulp stem cells. To learn more about the utility of dental pulp stem cells in emerging regenerative therapies and to learn how to bank your own valuable stem cells, visit StemSave or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The future of Regenerative Medicine is now™.